The lapse of federal COVID-19 funding: implications for health equity.
作者信息
Kobayashi Kelsen, Miller-Fitzwater Anna, Grier Cherece, Montez Kimberly
机构信息
Department of Student Affairs, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Department of Pediatrics, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
出版信息
Pediatr Res. 2023 Mar;93(4):745-747. doi: 10.1038/s41390-023-02487-4. Epub 2023 Jan 23.
Abstract
摘要
相似文献
1
The lapse of federal COVID-19 funding: implications for health equity.
Pediatr Res. 2023 Mar;93(4):745-747. doi: 10.1038/s41390-023-02487-4. Epub 2023 Jan 23.
2
Emergency COVID-19 funding to general practices in early 2020: lessons for future allocation to support equity.
N Z Med J. 2021 Jul 9;134(1538):102-110.
3
Health Equity and the Allocation of COVID-19 Provider Relief Funds.
Am J Public Health. 2021 Apr;111(4):628-631. doi: 10.2105/AJPH.2020.306127. Epub 2021 Feb 4.
4
Equity in health financing of Guangxi after China's universal health coverage: evidence based on health expenditure comparison in rural Guangxi Zhuang autonomous region from 2009 to 2013.
Int J Equity Health. 2017 Sep 29;16(1):174. doi: 10.1186/s12939-017-0669-9.
5
Create a COVID-19 commission.
Science. 2021 Nov 19;374(6570):932-935. doi: 10.1126/science.abk0029. Epub 2021 Nov 18.
6
Improving Affordability and Equity in Medicare Advantage.
Inquiry. 2019 Jan-Dec;56:46958019852873. doi: 10.1177/0046958019852873.
7
[Primary health care policy in Brazil: notes on Federal regulation and funding].
Cad Saude Publica. 2010 Apr;26(4):693-705. doi: 10.1590/s0102-311x2010000400012.
8
Embedding Equity in a Local Government's Response to COVID-19.
J Public Health Manag Pract. 2022;28(Suppl 1):S54-S57. doi: 10.1097/PHH.0000000000001429.
9
US COVID-19 Vaccine Costs Expected to Soar if Funding for Federal Program Ends.
JAMA Health Forum. 2022 Dec 2;3(12):e225376. doi: 10.1001/jamahealthforum.2022.5376.
10
Understanding the effectiveness of government health expenditure in improving health equity: Preliminary evidence from global health expenditure and child mortality rate.
Int J Health Plann Manage. 2019 Oct;34(4):e1968-e1979. doi: 10.1002/hpm.2837. Epub 2019 Jun 21.
本文引用的文献
1
Assessing Disparities in COVID-19 Testing Using National COVID Cohort Collaborative.
Stud Health Technol Inform. 2022 Jun 29;295:316-319. doi: 10.3233/SHTI220726.
2
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
JAMA. 2022 Jun 14;327(22):2210-2219. doi: 10.1001/jama.2022.7493.
3
BNT162b2 Protection against the Omicron Variant in Children and Adolescents.
N Engl J Med. 2022 May 19;386(20):1899-1909. doi: 10.1056/NEJMoa2202826. Epub 2022 Mar 30.
4
Pediatrician's role in vaccinating children and families for COVID-19: no one left behind.
Pediatr Res. 2021 Dec;90(6):1105-1107. doi: 10.1038/s41390-021-01804-z. Epub 2021 Nov 24.
5
COVID-19 in children. II: Pathogenesis, disease spectrum and management.
J Paediatr Child Health. 2022 Jan;58(1):46-53. doi: 10.1111/jpc.15811. Epub 2021 Oct 25.
6
Predictors of Vaccine Hesitancy: Implications for COVID-19 Public Health Messaging.
Int J Environ Res Public Health. 2021 Jul 29;18(15):8054. doi: 10.3390/ijerph18158054.
7
Impact of COVID-19 on Mental Health in Adolescents: A Systematic Review.
Int J Environ Res Public Health. 2021 Mar 3;18(5):2470. doi: 10.3390/ijerph18052470.
8
Disparities in H1N1 Vaccination Rates: a Systematic Review and Evidence Synthesis to Inform COVID-19 Vaccination Efforts.
J Gen Intern Med. 2021 Jun;36(6):1734-1745. doi: 10.1007/s11606-021-06715-7. Epub 2021 Mar 31.
9
Evidence-Based Strategies for Clinical Organizations to Address COVID-19 Vaccine Hesitancy.
Mayo Clin Proc. 2021 Mar;96(3):699-707. doi: 10.1016/j.mayocp.2020.12.024. Epub 2020 Dec 30.
10
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
Zotero 插件